US Pharma MarketingThe company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.
Artera gets FDA clearance for AI breast cancer risk prediction tool
Artera gets FDA clearance for AI breast cancer risk prediction tool is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive